American Water Works Company Inc vs AstraZeneca plc — how do they compare? American Water Works Company Inc trades at $131.69 (market cap $25.69B), while AstraZeneca plc trades at $166.95 (market cap $258.17B). The key difference: AstraZeneca plc is far larger — about 10× American Water Works Company Inc's market cap, and American Water Works Company Inc pays the higher dividend (2.72%). Which is the better fit depends on your goals.
| AWK | AZN | |
|---|---|---|
Market Cap | $25.69B | $258.17B |
Sector | Utilities | Health |
52-Week High | $147.00 | $209.48 |
52-Week Low | $121.13 | $137.44 |
Enterprise Value | $41.25B | $284.41B |
Dividend Yield | 2.72% | 1.87% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
AstraZeneca (AZN) trades at $169.47, down 1.25% amid recent volatility following a Phase III trial failure for Wainua. The stock shows bearish technical signals with key support at $168 and resistance at $170. Fundamentally, the company reported strong 2025 results with revenue of $58.74B and net income of $10.23B, though a recent $1.5B licensing deal for a lung cancer drug highlights ongoing pipeline investments. Analyst sentiment is mixed with 47.5% buy ratings but recent downgrades from firms like HSBC citing trial setbacks.
The outlook balances robust financials against pipeline execution risks. Revenue growth and high margins support valuation, but the Wainua failure raises concerns about future catalysts. Investors should weigh the company's strong cash flow and market position against clinical trial volatility and potential legal investigations. Near-term price action may hinge on Q2 2026 earnings due July 27, 2026.
Trailing returns across standard periods
Latest headlines on both assets
American Water Works is the largest investor-owned U.S. water and wastewater utility, serving approximately 3.5 million customers in 16 states. It provides water and wastewater services to residential, commercial, and industrial customers and operates predominantly in regulated markets. The company's only nonregulated business is water services for military bases, which operates under long-term contracts.
Read more on AWK →A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →